胃癌診療 -内視鏡治療と予防の最前線-
|
|
|
- あつみね かたいわ
- 9 years ago
- Views:
Transcription
1 K net
2
3
4
5
6
7 K net
8 K net
9 2 2 RCT LECS NOTES
10 19 2
11
12
13 Narrow Band Imaging Light Penetration Depth Light penetration depth within the tissue highly depends on the wavelength. Narrowing bandwidth can enhance the differences in the penetration depth between wavelengths.
14 NBI
15 RCT Lancet 2008
16
17 P<0.001 Uemura et al., N Engl J Med 2001
18 (%) 10g 40 6 (15%) 37g 24 8 (33%) 78g 25 9 (36%) 154g 30 19(63%) 10g 27 0 ( 0%) 38g 25 0 ( 0%) 81g 25 1 ( 4%) 165g 27 0 ( 0%) Int J Cancer 2006
19
20
21 IV CagA CagA CagA
22 CagA
23
24 6 Asaka et al. Gastroenterology 1992
25
26
27 QuickTimeý Dz H.264 êlí ÉvÉçÉOÉâÉÄ Ç Ç±ÇÃÉsÉNÉ`ÉÉǾå ÇÈÇžÇ½Ç ÇÕïKóvÇ-ÇÅB
28 Uemura et al, Cancer Epi Bio Prev 1997
29 RCT Lancet 2008
30
31 % % P=0.04 (Log rank test)
32 J Gastroenterol 2007; 41: 21-7.
33
34
35
36
37
38
39
40 (IIIA,T3N1M0) 5.4 Before eradication After 2 months 1.2 years 2.9 years 5.4 years 2.5 years later
41
42 LECS:Laparoscopy and Endoscopy Combined Surgery NOTES Normal Orifice Transluminal Endoscopic Surgery
43
44 LECS:Laparoscopy and Endoscopy Combined Surgery
45 LECS
46 EBM ( 2
知っておきたいCT検査技術 ー 頸部 CT-A ー
CT CT- QuickTimeý Dz êlí ÉvÉçÉOÉâÉÄ Ç Ç±ÇÃÉsÉNÉ`ÉÉǾå ÇÈÇžÇ½Ç ÇÕïKóvÇ-ÇÅB QuickTimeý Dz êlí ÉvÉçÉOÉâÉÄ Ç Ç±ÇÃÉsÉNÉ`ÉÉǾå ÇÈÇžÇ½Ç ÇÕïKóvÇ-ÇÅB QuickTimeý Dz êlí ÉvÉçÉOÉâÉÄ Ç Ç±ÇÃÉsÉNÉ`ÉÉǾå ÇÈÇžÇ½Ç ÇÕïKóvÇ-ÇÅB
437“ƒ
et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer
untitled
3 4 5 6 7 8 9 10 11 12 13 14 15 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 73 74 75 76 77
H1-H4_0906 [更新済み]
![H1-H4_0906 [更新済み]](/thumbs/43/23136860.jpg "H1-H4_0906 [更新済み]")
0570-016-100 Q&A 0570-016-100 1 2 3 4 5 1 23 123 0570-064-717 1 2 3 0570-016-100 0570-016-100 3 1 2 Q&A Q &A After Before After Before After Before After Before Before After Before Before After
「産業上利用することができる発明」の審査の運用指針（案）
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
01 カラーリバーサル現像 NEW
ブローニー 6 6 6 4.5 ブローニー 6 7 6 8 9 ブローニー 6 6 6 4.5 ブローニー 6 7 6 8 9 ブローニー 6 6 6 4.5 ブローニー 6 7 6 8 9 2339 1654 3307 2339 4000 2803 3291 2677 3441 4252 4000 6000 3803 2591 1362 945 1630 1268 1929 1543 2323
79 79 1989 12 10 15 13 1998 2000 2
78 79 10 12 11 1 79 79 1989 12 10 15 13 1998 2000 2 78 78 78 2000 78 10 35 7 8 2002 6 0 00 2003 7 8 20 21 3 1 4 2001 2001 70 2001 2001 233 186 47 21 84 5 30 21 2004 4 27 31 2001 90 27 31 2001 1 2 3 4 28
1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing
12 20 21 23 25 37 41 52 60 65 67 71 72 73 76 77 86 94 11 12 12 11 16 13 13 43 13 91 14 [ 12 20 10 10 26 10 29 10 12 12 23 12 12 15 11 27
è è è è è è è è è 41 41 23 41 10 20 41 11 24 52 21 15 29 24 10 10 11 10 11 20 10 12 10 12 11 30 11 11 11 10 13 13 30 19 10 12 23 11 11 29 10 10 21 21 19 11 10 14 17 26 27 10 17 22 27 13 17 18 11 11 12
N 847 1085 1932 2966 3336 6302 % 43.8 56.2 100 47.1 52.9 100 28 72 41.34 28 77 51.52 N 84 750 580 478 28 12 1932 % 4.3 38.8 30.0 24.7 1.4 0.6 100 N 1079 2710 1318 1083 60 52 6302 % 17.1 43.0 20.9 17.2
2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1
がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性
2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
審査報告書（案）
19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET
! 1Munderl P et al. Survival and causes of death, 2 years after Introduction of antiretroviral therapy in Africa. XVI International AIDS Conference, 2006, Abstract THLB0208. 2Walensky RP et al. The
日本皮膚科学会雑誌第121巻第12号
Geriatrics Akt Dermato Eur J Vasc Endovasc Surg Ann R Coll Surg Engl Br J Surg Cochrane Database Syst Rev Cochrane Database Syst Rev Cochrane Database Syst Rev Cochrane Database Syst Rev Int wound J Eur
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
Postoperative Assessment by Using a Torque Machine (BIODEX) and MRIs in Patients treated for a Recurrent Anterior Dislocation or Subluxation of the Sh
Postoperative Assessment by Using a Torque Machine (BIODEX) and MRIs in Patients treated for a Recurrent Anterior Dislocation or Subluxation of the Shoulder by HATA Yukihiko MURAKAMI Narumichi Department
3 4 6 7 8 9 10 12 14 2 3
3 4 6 7 8 9 10 12 14 2 3 POINT 4 5 3053 1323 4 7 6 1 1 4 7 Yamada N. et al : Int J Cardiol. 98, 409-411, 2005 6 7 POINT 0 20 40 60 80 100 60 80 Ota M. et al: Heart Vessels. 17, 7-11,2002 40 60 20 50 15
02
54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148
The Most Effective Exercise for Strengthening the Supraspinatus : Evaluation by Magnetic Resonance Imaging by TAKEDA Yoshitsugu and ENDO Kenji Departm
The Most Effective Exercise for Strengthening the Supraspinatus : Evaluation by Magnetic Resonance Imaging by TAKEDA Yoshitsugu and ENDO Kenji Department of Orthopedic Surgery, The University of Tokushima
食道がん化学放射線療法後のsalvage手術
2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573
untitled
21 22 23 24 25 26 27 28 29 30 31 32 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91
EVIS LUCERA ELITE EVIS LUCERA ELITE 2 3
Advancing the Art of Endoscopy EVIS LUCERA ELITE EVIS LUCERA ELITE 2 3 HQ NBI Narrow Band Imaging CCD NBINBI EVIS LUCERA ELITE NBI EVIS LUCERA ELITENBI HQ EVIS LUCERA ELITE EVIS LUCERA SPECTRUM GIF-HQ290
1
1 2 Before After 1 2 3 4 3 4 5 6 1010022 3 1010022 3 0630814 130 9800021 92713 9638041 322 1010022 3 9500892 15 2230057 7601 3920012 24082 1920033 217 3120063 16462 9398205 443 4568544 1617 4170034 26118
untitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J
表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
膵癌超音波診(案)
1 2 3 4 5 6 7 8 9 10 2009 7 6 2 a. invasive ductal carcinoma * 1 b. endocrine neoplasm c. Solid pseudopapillary neoplasm d. tumor producing pancreatitis * 2 * 1 invasive ductal carcinomas papillary adenocarcinoma
untitled
HBV HBV (1964) HDV (1977) HCV (1988) 2009 Yotsuyanagi H et al. J Med Virol 2005 Yotsuyanagi H et al. J Hepatol 2002 Universal vaccination (UV) 45 HB 2009 1/3 Progress Toward the Elimination
日本消化器外科学会雑誌第30巻第3号
Key words : gastric cancer, progltostic factor. multivariate analysis Factors selected after Coffelation- after Stepwise rnitrally check check H o s t l A g e C O 2 S e x C O 3 Pre-op. compliation O Treatment
40: 127-130, 1994 11) Damjanov I, Moriber K, Catalano E, et al: Myelolipoma in a heterotopic adrenal gland. Light and electron microscopic findings. Can cer 44: 1350-1356, 1979 12) DeNavasquez S: Case
終末期の呼吸困難症状への対応*松坂最終修正
Clinical Question 2017 5 27 1 PCOC 1. 12778 ( 55%, 45% NRS. 1 54, 35%. NRS. NRS,,,,,,,, Performance status, Ekstrom, M., et al.2016 J Pain Symptom Manage 51(5):816-23. . 1 85 ADL. 3,,,,. JCS200,, 40 /,
H1-P15
72 January 2009 72 January 2009 72 January 2009 2008 GFP GFP 1992 Prasher cdna GFP Aequorea victoria GFP cdna in vivo EGFP GFP FACS GFP GFP GFP GFP 1. Prasher, D.C., et al. 1992. Primary structure of the
Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery
Arthroscopic Treatment for Painful Bennett Lesions of the Shoulder in Baseball Players by M. Yoneda and K. Hayashida Department of Orthopaedic Surgery, Osaka Kosei-Nenkin Hospital K. Izawa and S. Wakitani
Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Labor
Effect of Trimoprostil on Gastric Secretion Takeshi KAWAMURA * Hiroko EBINA * Fumiaki KOIZUMI * and Akira ISHIMORI * *Department of Clinical and Laboratory Medicine University School of Medicine, Tohoku
分子標的薬アプデート 2018
Primary imatinib, 2002-2008 (CML IV) 5-year survival 93% n = 2830 Survival probability IFN or SCT, 1997-2008 (CML IIIA) 5-year survival 71% IFN or SCT, 1995-2008 (CML III) 5-year survival 63% IFN, 1986-2003